PUBLICATIONS

Chercher par auteur :
Tous les AuteursAlcaraz GAmendola JAnkri NAziz AAzzaz FBaudot PBialowas ABoudkkazi SBoumedine NBrechet ACaillard OCampanac ECarlier EChahinian HCoq JOCudmore RHDaoudal GDe San Feliciano MDebanne DDebreux KDenis DDesplantes RDi Giovanni JDubruc FDufour MDuménieu MDéglise PEl Far OExtrémet JFantini JFormisano-Treziny CFronzaroli-Molinieres LFékété AGabert JGasselin CGastrein PGiraud PGoaillard JMHaddjeri-Hopkins AIborra CIncontro SInglebert YLEVEQUE CLopez CLévêque CMarcaggi PMarqueze BMarra VMaulet YMoubarak EMoutot NRama SRamirez-Franco JJRussier MSammari MSangiardi MSeagar MSourdet VTapia MTell FTemporal SUsseglio FWakade AWoodhouse AYahi NYoussouf FZanin EZbili M

Chercher par année de publication :
Toutes les Années2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987198619841983198219811980197919781974

Chercher par mot-clé :

	PUBLICATIONS
ACCUEIL   |  PUBLICATIONS

ANNEE : 2012

Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episodes

AUTEURS : Belzeaux R, Bergon A, Jeanjean V, Loriod B, , Formisano-Treziny C, Verrier L, Loundou A, Baumstarck-Barrau K, Boyer L, Gall V, , Gabert J, Nguyen C, Azorin JM, Naudin J, Ibrahim EC.

REVUE : Translational Psychiatry
 To date, it remains impossible to guarantee that short-term treatment given to a patient suffering from a major depressive episode (MDE) will improve long-term efficacy. Objective biological measurements and biomarkers that could help in predicting the clinical evolution of MDE are still warranted. To better understand the reason nearly half of MDE patients respond poorly to current antidepressive treatments, we examined the gene expression profile of peripheral blood samples collected from 16 severe MDE patients and 13 matched controls. Using a naturalistic and longitudinal design, we ascertained mRNA and microRNA (miRNA) expression at baseline, 2 and 8 weeks later. On a genome-wide scale, we detected transcripts with roles in various biological processes as significantly dysregulated between MDE patients and controls, notably those involved in nucleotide binding and chromatin assembly. We also established putative interactions between dysregulated mRNAs and miRNAs that may contribute to MDE physiopathology. We selected a set of mRNA candidates for quantitative reverse transcriptase PCR (RT-qPCR) to validate that the transcriptional signatures observed in responders is different from nonresponders. Furthermore, we identified a combination of four mRNAs (PPT1, TNF, IL1B and HIST1H1E) that could be predictive of treatment response. Altogether, these results highlight the importance of studies investigating the tight relationship between peripheral transcriptional changes and the dynamic clinical progression of MDE patients to provide biomarkers of MDE evolution and prognosis.